Skip to main content
CorVista
A gray-haired man in a sweater with his arms folded on a fence

Delivering answers that matter.

Discover how CorVista aids life-saving diagnosis—right when it is needed most.

Closing the Care Gap for Millions.

30%

More likely for Black Americans to die from CVD than white Americans

24%

More likely for women with Coronary Artery Disease to be misdiagnosed

22M

Americans don't have access to a cardiologist in their county
A man in a field wearing autumn gear and headphones, eyes closed.

Revolutionizing cardiovascular care at the point of need.

At CorVista, we believe that true innovation isn’t just about advancing technology—it’s about transforming patient care for everyone, everywhere.

Discover How

CorVista System

One Test. Life-Saving Potential.
A device with a CorVista logo on the screen, with wires attached.

3.5 Minutes

to capture comprehensive CV data.

Non-invasive

No Stress tests. No radiation. No hassle.

Front-line Test

helping to move care delivery upstream and out of the hospital.
A laptop on a desk with a data dashboard on the screen.

Scalable

technology requiring only an internet connection.

Cloud-Based Processing

to reach even the most remote patients.

Same-day Results

delivered via our physician web portal in less than 30 minutes.

Changing the Path to Heart Health

 a flowchart showing the difference between a Corvista patient's journey vs a slower, common journey with multiple doctor visits.

We turn an 8-week diagnostic journey into one 30-minute test.

Explore our latest news.
CorVista Health Demonstrates High-Sensitivity for Noninvasive Detection of CAD including INOCA (Ischemia with No Obstructed Coronary Arteries) at ACC.26
MAR 30, 2026

CorVista Health Demonstrates High-Sensitivity for Noninvasive Detection of CAD including INOCA (Ischemia with No Obstructed Coronary Arteries) at ACC.26

CorVista Health to Present New Data on Non-Invasive Point of Care Test for Ischemia with Non-Obstructive Coronary Arteries Using Machine Learning at ACC.26
MAR 25, 2026

CorVista Health to Present New Data on Non-Invasive Point of Care Test for Ischemia with Non-Obstructive Coronary Arteries Using Machine Learning at ACC.26

Utility of a Novel Point-of-Care Test in Detecting Coronary Artery Disease Following Negative Nuclear Testing: A Case Series
JAN 23, 2026

Utility of a Novel Point-of-Care Test in Detecting Coronary Artery Disease Following Negative Nuclear Testing: A Case Series

Moving advanced cardiovascular diagnostics out of the hospital to the frontline of care.

The CorVista System is the world’s first digital health solution, approved to aid the diagnosis of both pulmonary hypertension (PH) and coronary artery disease (CAD) in a single, non-invasive test.

 A middle-aged woman drinking a green juice out of a class, looking out the window.